Artemis licenses diagnostics from Stanford
Exercising its recently raised $20 million third funding round, Artemis Health has licensed non-invasive prenatal diagnostic technology from Stanford University. Initially, it licensed intellectual property from Massachusetts General Hospital and the Massachusetts Institute of Technology but has mostly been working in stealth mode since.
The acquisition is expected to help Artemis develop a fetal monitoring system superior to a typical amniocentesis. For example, the Stanford technology could help identify trisomy disorders like Down syndrome more easily. In the meantime, Artemis is continuing with internal trials of its diagnostic products and expects to launch its first within a year.
The last investment round, raised in September, came from Sutter Hill Ventures, Alloy Ventures and Mohr Davidow Ventures.
Next Story: Appirio helps companies reach your Facebook friends
Previous Story: Hearing aid maker Sonitus lands $13.5M
About the Author, Camille Ricketts
Camille is the lead writer for GreenBeat. She came to VentureBeat from Google where she worked on its traditional platforms team, particularly in TV. Before that, she was a reporter for the Wall Street Journal in New York and London. Follow her on Twitter at @camillericketts, and follow VentureBeat on Twitter at @venturebeat.
With GreenBeat 2009, VentureBeat's all-star conference on all things Smart Grid, coming up in November, Camille will be expanding coverage of this exciting space. Stay up to date by following @greenbeat2009 on Twitter or by becoming a fan of the event on Facebook here.